Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

FASEB Journal

Volumn 16, Issue 1, 2002, Pages 61-71

  Galon, Jérôme ^a,c,g   Franchimont, Denis ^b,d   Hiroi, Naoki ^b,f   Frey, Gregory ^b   Boettner, Antje ^e   Ehrhart Bornstein, Monika ^b,f   O'Shea, John J ^a   Chrousos, George P ^b   Bornstein, Stefan R ^b,f  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c INSTITUT CURIE   (France)

^d ERASME HOSPITAL   (Belgium)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g INSERM   (France)

Author keywords

Clinical medicine; DNA microarray; Immune system

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; DEXAMETHASONE; DOWN-REGULATION; GENE EXPRESSION PROFILING; GLUCOCORTICOIDS; HLA ANTIGENS; HUMANS; INTEGRINS; LYMPHOCYTE ACTIVATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; T-LYMPHOCYTES; UP-REGULATION;

EID: 0036135774     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0245com     Document Type: Article

References (42)

1. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
2. Neuroendocrine-immune system interactions and atttoimmunity
3. Enhancing versus suppressive effects of stress hormones on skin immune function
4. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions
5. Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates
6. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
7. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children
8. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial
9. Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: Time for a critical reappraisal
10. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
11. Glucocorticoids in T cell development and function
12. Glucocorticoids and immune function: Unknown dimensions and new frontiers
13. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: Potential regulation of the glucocorticoid receptor
14. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes
15. Glucocorticosteroids inhibit mRNA expression for cotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia
16. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines
17. The type II 'receptor' as a decoy target for interleukin 1 in polymorphonuclear leukocytes: Characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor
18. Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin
19. The role of complement and complement receptors in induction and regulation of immunity
20. Cytokines and proteases in invasive processes: Molecular similarities between inflammation and cancer
21. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene
22. The cell biology of thrombospondin-1
23. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163)
24. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli
25. Toll-like receptors in the induction of the innate immune response
26. The role of Toll-like receptors in host defense against microbial infection
27. Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation?
28. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy
29. Inhibition of Th1 immune response by glucocorticoids: Dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes
30. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes
31. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes
32. Generation of antigen-specific Th2 cells from unprimed mice in vitro: Effects of dexamethasone and anti-IL-10 antibody
33. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes
34. Discovering the role of the major histocompatibility complex in the immune response
35. Nonclassical MHC class II molecules
36. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
37. Interleukin-10-deficient mice develop chronic enterocolitis
38. Nuclear receptor coregulators: Cellular and molecular biology
39. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma
40. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids
41. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections
42. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis